Susanna E. Kallioinen

Susanna E. Kallioinen

Auto-generated profile, based on publicly available information

Susanna E. Kallioinen

Department of Nuclear Medicine University Hospitals, Coventry and Warwickshire NHS Trust Coventry UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Journal of General Virology
Verified
Journal Article
Open access
GLGarry A. Luke
Garry A. Luke
PFPablo de Felipe
Pablo de Felipe
ALAlexander Lukashev
Alexander Lukashev
SKSusanna E. Kallioinen
Susanna E. Kallioinen
EBElizabeth A. Bruno
Elizabeth A. Bruno
MRMartin Ryan
Martin Ryan
2A is an oligopeptide sequence mediating a ribosome ‘skipping’ effect, producing an apparent ‘cleavage’ of polyproteins. First identified and characterized in picornaviruses, ‘2A-like’ sequences are found in other mammalian viruses and a wide range of insect viruses. Databases were analysed using a motif conserved amongst 2A/2A-like sequences. The newly identified 2A-like sequences (30 aa) were inserted into a reporter polyprotein to determine their cleavage activity. Our analyses showed that these sequences fall into two categories. The majority mediated very high (complete) cleavage to separate proteins and a few sequences mediated cleavage with lower efficiency, generating appreciable levels of the uncleaved form. Phylogenetic analyses of 2A-like sequences and RNA-dependent RNA polymerases (RdRps) indicated multiple, independent, acquisitions of these sequences at different stages during virus evolution. Within a virus family, 2A sequences are (probably) homologous, but diverge due to other evolutionary pressures. Amongst different families, however, 2A/2A-like sequences appear to be homoplasic.

1 December 2017 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
PDPrudence Donovan
Prudence Donovan
ODOlivier A. Dubey
Olivier A. Dubey
SKSusanna Kallioinen
Susanna Kallioinen
KRKatherine W. Rogers
Katherine W. Rogers
KMKatja Muehlethaler
Katja Muehlethaler
Daniel ConstamDaniel Constam
Daniel Constam
The secreted growth factor Activin-A of the transforming growth factor β family and its receptors can promote or inhibit several cancer hallmarks including tumor cell proliferation and differentiation, vascularization, lymphangiogenesis and inflammation. However, a role in immune evasion and its relationship with tumor-induced muscle wasting and tumor vascularization, and the relative contributions of autocrine versus paracrine Activin signaling remain to be evaluated. To address this, we compared the effects of truncated soluble Activin receptor IIB as a ligand trap, or constitutively active mutant type IB receptor versus secreted Activin-A or the related ligand Nodal in mouse and human melanoma cell lines and tumor grafts. We found that although cell-autonomous receptor activation arrested tumor cell proliferation, Activin-A secretion stimulated melanoma cell dedifferentiation and tumor vascularization by functional blood vessels, and it increased primary and metastatic tumor burden and muscle wasting. Importantly, in mice with impaired adaptive immunity, the tumor-promoting effect of Activin-A was lost despite sustained vascularization and cachexia, suggesting that Activin-A promotes melanoma progression by inhibiting antitumor immunity. Paracrine Activin-A signaling emerges as a potential target for personalized therapies, both to reduce cachexia and to enhance the efficacy of immunotherapies.

1 February 2008 in Journal of General Virology
Verified
Journal Article
Closed access
GFGarth Funston
Garth Funston
SKSusanna E. Kallioinen
Susanna E. Kallioinen
PFPablo de Felipe
Pablo de Felipe
MRMartin D. Ryan
Martin D. Ryan
RIRichard D. Iggo
Richard D. Iggo
Insertion of picornaviral 2A sequences into mRNAs causes ribosomes to skip formation of a peptide bond at the junction of the 2A and downstream sequences, leading to the production of two proteins from a single open reading frame. Adenoviral protein IX is a minor capsid protein that has been used to display foreign peptides on the surface of the capsid. We have used 2A sequences from the foot-and-mouth disease virus (FMDV) and porcine teschovirus 1 (PTV-1) to express protein IX (pIX) and green fluorescent protein (GFP) from pIX–2A–GFP fusion genes in an oncolytic virus derived from human adenovirus 5. GFP was efficiently expressed by constructs containing either 2A sequence. Peptide bond skipping was more efficient with the 58 aa FMDV sequence than with the 22 aa PTV-1 2A sequence, but the virus with the FMDV 2A sequence showed a reduction in plaque size, cytopathic effect, viral burst size and capsid stability. We conclude that ribosome skipping induced by 2A sequences is an effective strategy to express heterologous genes in adenoviruses; however, careful selection or optimization of the 2A sequence may be required if protein IX is used as the fusion partner.

18 September 2026 in Head & Neck
Verified
Journal Article
Closed access
GWGary M. Walton
Gary M. Walton
OAOludolapo Adesanya
Oludolapo Adesanya
LRLisa Rowley
Lisa Rowley
SKSusanna E. Kallioinen
Susanna E. Kallioinen
ATAlica Torres‐Rendon
Alica Torres‐Rendon
PNPrady Naredla
Prady Naredla